Thrombomodulin prolongs thrombin-induced extracellular signal-regulated kinase phosphorylation and nuclear retention in endothelial cells

Circulation Research

Volumn 88, Issue 7, 2001, Pages 681-687

  Olivot, J M ^a   Estebanell, E ^a   Lafay, M ^a   Brohard, B ^a   Aiach, M ^a   Rendu, F ^a  

^a INSERM   (France)

Author keywords

Human endothelial cells; Mitogen activated protein kinase; Thrombin; Thrombomodulin

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MONOCLONAL ANTIBODY; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBOMODULIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; DNA SYNTHESIS; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; INTRACELLULAR TRANSPORT; MITOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

EID: 0035853404     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh0701.088769     Document Type: Article

References (40)

1. Cellular consequences of thrombin-receptor activation
2. How the protease thrombin talks to cells
3. Solution structure of the smallest cofactoactive fragment of thrombomodulin
4. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
5. Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase
6. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: Evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand
7. Surface thrombomodulin modulates thrombin receptor responses on vascular smooth muscle cells
8. Design and validation of a new immunoassay for soluble forms of thrombomodulin and studies on plasma
9. Thrombomodulin modulates the mitogenic response to thrombin of human umbilical vein endothelial cells
10. Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity
11. Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase
12. Activation mechanism of the MAP kinase ERK2 by dual phosphorylation
13. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation
14. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
15. Thrombin and its receptor in growth control
16. cPLA2 is phosphorylated and activated by MAP kinase
17. 2 release but has no effect on von Willebrand factor secretion or E-selectin expression
18. Glu-192 to Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin
19. Culture of human endothelial cells derived from umbilical veins: Identification by morphologic and immunologic criteria
20. MAP kinase abnormalities in hyperproliferative cultured fibroblasts from psoriatic skin
21. A synthetic inhibitor of the mitogen-activated protein kinase cascade
22. Thrombin mitogenic responses and protein phosphorylation are different in cultured human endothelial cells derived from large and microvessels
23. Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling
24. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry
25. Nuclear fusion of signaling pathways
26. Transcriptional regulation by extracellular signals: Mechanisms and specificity
27. Evidence for the presence of a proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells
28. The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells
29. Dual specificity phosphatases: A gene family for control of MAP kinase function
30. Reduced MAP kinase phosphatase-1 degradation after p42/p44 MAPK-dependent phosphorylation
31. MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia
32. Activation of mitogen-activated protein kinases in in vivo ischemia/reperfused myocardium in rats
33. Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats
34. Brain embolism is a dynamic process with variable characteristics
35. Regulation of brain capillary endothelial thrombomodulin mRNA expression
36. Brain-specific protein C activation during carotid artery occlusion in humans
37. Transforming growth factor-β mediates astrocyte-specific regulation of brain endothelial anticoagulant factors
38. Endothelial cells exhibiting angiogenesis in vitro proliferate in response to TGF-β1
39. Defects in natural anticoagulant pathways as potential risk factors for myocardial infarction
40. Thrombomodulin gene mutations associated with myocardial infarction